US Biotech Share Sales Deliver Biggest First Week Since 2021
Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology fundraising after turbulence in the sector last year.
By Anthony Hughes, Angel Adegbesan · Bloomberg Markets
Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology fundraising after turbulence in the sector last year.